SK Bioscience

Fina Biosolutions is a biotechnology company focused on developing and manufacturing complex conjugate vaccines. It provides bioconjugation, protein expression and purification, immunoassay design, analytics, training, and consulting services. The company operates in the research and development stage, applying proprietary chemistry to conjugate, purify, and manufacture vaccine conjugates with the aim of preventing life-threatening diseases and lowering vaccine costs.

Sunflower Therapeutics is a biotechnology company specializing in next-generation protein manufacturing solutions. It aims to enhance global patient access to biological medicines by developing and implementing advanced technologies that benefit worldwide populations. The company employs strain engineering, integrated process development, and automated multi-product facilities to create efficient and scalable production methods.

Novavax is a biotechnology company focused on discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Its portfolio centers on nanoparticle vaccines using the Matrix-M adjuvant to elicit strong immune responses, including ResVax for respiratory syncytial virus delivered through maternal immunization and NanoFlu for seasonal influenza in older adults, with both candidates advancing through late-stage clinical trials. The company is advancing additional vaccine programs such as RSV vaccines for older adults and young children, as well as candidates against Ebola and a combined influenza and RSV vaccine. It collaborates with Takeda for NVX-CoV2373, a COVID-19 vaccine candidate, and operates globally via its development and commercialization platform. Founded in 1987 and headquartered in Gaithersburg, Maryland, Novavax pursues vaccines across multiple stages of clinical development to address urgent health needs.